Qu Biologics’ Immunomodulator Improves Fatty Liver Disease
06. Januar 2025 08:00 ET
|
Qu Biologics, Inc.
BURNABY, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel immunomodulation...